Jumping to a high dose too quickly can overwhelm your system, leading to more pronounced and uncomfortable side effects, which can be discouraging and make it difficult to continue treatment
Conclusions The results of this large population-based cohort study indicate that in patients with NAFLD and type 2 diabetes, GLP-1RAs and SGLT2 inhibitors are associated with lower incidences of macrovascular diseases and all-cause mortality compared with other glucose-lowering drugs
Its common to experience mild redness, warmth, or itching that subsides within 2448 hours
These articles discussed how GLP-1 RA uses the effect of delayed gastric emptying, the half-lives of these medications, and increased RGC and pulmonary aspiration risk
This allows the body to adjust to the medication, potentially reducing the severity of side effects such as nausea, vomiting, and diarrhoea
Timing Follow-up Marker Fasting glucose Why it matters IGF-related activity can affect glucose handling, so current glucose context matters